Drug shortage
Delayed Release · Eli Lilly and Co.
FDA drug shortage · To Be Discontinued · updated Oct 18, 2024
Key facts
| Generic name | Delayed Release, Duloxetine Hydrochloride Capsule |
|---|---|
| Proprietary name | Cymbalta |
| Company | Eli Lilly and Co. |
| Presentation | Cymbalta, Capsule, Delayed Release, 20 mg (NDC 0002-3235-60) |
| Dosage form | Capsule, Delayed Release |
| Strength | 20 mg |
| Status | To Be Discontinued |
| Therapeutic category | Psychiatry |
| Package NDCs | 0002-3235-60 |
| First posted | Oct 18, 2024 |
| Last updated | Oct 18, 2024 |
| Discontinued | Oct 18, 2024 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: